Dethlefs Sven

EVP, North America Commercial | EVP Global Marketing&Portfolio

1 company

Weak

Trades Analyzed

12M Win Rate

0.0%

Avg 3M Return

+4.5%

Avg 12M Return

-29.5%

Dethlefs Sven is an EVP, North America Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD. Recent SEC Form 4 filings include 0 buys and 14 sells.

Estimated insider holdings value: $6.0M based on current market prices.

Holdings by Company

TEVAMar 7, 2023

Current Shares165.4K

Value$6.00M

Net Activity-208,060

Bought: 2.0KSold: 210.1K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 7, 2023	TEVA Teva Pharmaceutical Industries Ltd	EVP, North America Commercial	Sell	77,421	$9.55	$739,653.01	-16.6%	-23.6%	+43.3%
Feb 28, 2023	TEVA Teva Pharmaceutical Industries Ltd	EVP, North America Commercial	Sale+OE	59,655	$9.89	$589,785.12	-15.3%	-27.2%	+32.1%
Mar 7, 2022	TEVA Teva Pharmaceutical Industries Ltd	EVP, North America Commercial	Sale+OE	10,897	$7.41	$80,727.01	-3.4%	+23.6%	+28.8%
Feb 28, 2022	TEVA Teva Pharmaceutical Industries Ltd	EVP, North America Commercial	Sale+OE	4,862	$8.14	$39,587.38	-4.7%	+11.9%	+21.9%
Feb 9, 2022	TEVA Teva Pharmaceutical Industries Ltd	EVP, North America Commercial	Sale+OE	4,138	$9.06	$37,491.11	-4.5%	-16.7%	+9.2%
Mar 4, 2021	TEVA Teva Pharmaceutical Industries Ltd	EVP Global Marketing&Portfolio	Sale+OE	6,012	$10.57	$63,523.39	-7.2%	-	-
Mar 3, 2021	TEVA Teva Pharmaceutical Industries Ltd	EVP Global Marketing&Portfolio	Sale+OE	606	$10.86	$6,582.74	-0.9%	-	-
Mar 1, 2021	TEVA Teva Pharmaceutical Industries Ltd	EVP Global Marketing&Portfolio	Sale+OE	7,486	$10.83	$81,079.37	-9.8%	-	-
Feb 9, 2021	TEVA Teva Pharmaceutical Industries Ltd	EVP Global Marketing&Portfolio	Sale+OE	29,657	$12.69	$376,480.79	-17.2%	-	-
Feb 10, 2020	TEVA Teva Pharmaceutical Industries Ltd	EVP Global Marketing&Portfolio	Sale+OE	5,669	$12.27	$69,558.63	-23.9%	-	-